BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9233592)

  • 1. Analysis of ETV6 and ETV6-AML1 proteins in acute lymphoblastic leukaemia.
    Agape P; Gerard B; Cave H; Devaux I; Vilmer E; Lecomte MC; Grandchamp B
    Br J Haematol; 1997 Jul; 98(1):234-9. PubMed ID: 9233592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value.
    Codrington R; O'Connor HE; Jalali GR; Carrara P; Papaioannou M; Hart SM; Hoffbrand AV; Potter M; Prentice HG; Harrison CJ; Foroni L
    Br J Haematol; 2000 Dec; 111(4):1071-9. PubMed ID: 11167742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A child with ALL and ETV6/AML1 fusion on a chromosome 12 due to an insertion of AML1 and loss of ETV6 from the homolog involved in a t(12;15)(p13;q15).
    Reddy KS; Yang X; Mak L; Wang S; Johnston M
    Genes Chromosomes Cancer; 2000 Oct; 29(2):106-9. PubMed ID: 10959089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.
    Cavé H; Cacheux V; Raynaud S; Brunie G; Bakkus M; Cochaux P; Preudhomme C; Laï JL; Vilmer E; Grandchamp B
    Leukemia; 1997 Sep; 11(9):1459-64. PubMed ID: 9305598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood acute lymphoblastic leukaemia with ider(21)(q10)t(12;21)(p12;q22): a new recurrent abnormality showing ETV6/CBFA2 fusion.
    Andreasson P; Johansson B; Strömbeck B; Donnér M; Mitelman F; Höglund M
    Br J Haematol; 1997 Jul; 98(1):216-8. PubMed ID: 9233588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
    Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
    Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
    [No Abstract]   [Full Text] [Related]  

  • 7. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
    Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H
    Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.
    Raynaud S; Cave H; Baens M; Bastard C; Cacheux V; Grosgeorge J; Guidal-Giroux C; Guo C; Vilmer E; Marynen P; Grandchamp B
    Blood; 1996 Apr; 87(7):2891-9. PubMed ID: 8639909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene.
    Thandla SP; Ploski JE; Raza-Egilmez SZ; Chhalliyil PP; Block AW; de Jong PJ; Aplan PD
    Blood; 1999 Jan; 93(1):293-9. PubMed ID: 9864173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of TEL proteins in human leukemias.
    Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
    Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood.
    Kempski HM; Sturt NT
    Leuk Lymphoma; 2000 Dec; 40(1-2):39-47. PubMed ID: 11426627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis.
    O'Connor HE; Butler TA; Clark R; Swanton S; Harrison CJ; Secker-Walker LM; Foroni L
    Leukemia; 1998 Jul; 12(7):1099-106. PubMed ID: 9665196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
    Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
    Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia.
    Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G
    Blood; 2004 Oct; 104(8):2452-7. PubMed ID: 15217836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization analysis of 12;21 translocation in Japanese childhood acute lymphoblastic leukemia.
    Eguchi-Ishimae M; Eguchi M; Tanaka K; Hamamoto K; Ohki M; Ueda K; Kamada N
    Jpn J Cancer Res; 1998 Jul; 89(7):783-8. PubMed ID: 9738986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
    Fears S; Chakrabarti SR; Nucifora G; Rowley JD
    Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
    de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
    Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.